The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders topical collection on child and adolescent disorders

Courtney A. Zulauf, Susan E. Sprich, Steven Safren, Timothy E. Wilens

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Adolescents and young adults with substance use disorders (SUD) and attention deficit/hyperactivity disorder (ADHD) are increasingly presenting in clinical practice. The overlap and role of treatment for these co-occurring disorders remains unclear. A review of the literature was conducted to highlight and update recent evidence on the overlap of ADHD and SUD, the role of ADHD medication on later SUD, and the treatment of ADHD and SUD in adolescents and young adults. Recent work continues to highlight the high risk for comorbid ADHD in patients with SUD; and conversely, the high risk for SUD developing in ADHD across the lifespan, particularly in the context of comorbid conduct disorder. Although the data remains discordant, it appears that ADHD pharmacotherapy does not increase the risk for SUD. Medication treatment alone does not appear to be particularly effective in treating SUD in currently active substance abusing individuals with ADHD. Structured therapies may be effective in treating adolescents and young adults with ADHD and SUD. Further controlled trials evaluating the sequence and effect of structured psychotherapies and/or ADHD pharmacotherapy on SUD relapse in these groups are warranted.

Original languageEnglish (US)
Article number436
JournalCurrent Psychiatry Reports
Volume16
Issue number3
DOIs
StatePublished - Mar 2014
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Substance-Related Disorders
Young Adult
Drug Therapy
Conduct Disorder
Therapeutics
Psychotherapy
Recurrence

Keywords

  • Adolescence
  • Attention deficit/hyperactivity disorder
  • Cognitive-behavioral therapy
  • Stimulants comorbidity
  • Substance use disorders

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders topical collection on child and adolescent disorders. / Zulauf, Courtney A.; Sprich, Susan E.; Safren, Steven; Wilens, Timothy E.

In: Current Psychiatry Reports, Vol. 16, No. 3, 436, 03.2014.

Research output: Contribution to journalArticle

@article{40038c56321447aa8218413ea9c889ea,
title = "The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders topical collection on child and adolescent disorders",
abstract = "Adolescents and young adults with substance use disorders (SUD) and attention deficit/hyperactivity disorder (ADHD) are increasingly presenting in clinical practice. The overlap and role of treatment for these co-occurring disorders remains unclear. A review of the literature was conducted to highlight and update recent evidence on the overlap of ADHD and SUD, the role of ADHD medication on later SUD, and the treatment of ADHD and SUD in adolescents and young adults. Recent work continues to highlight the high risk for comorbid ADHD in patients with SUD; and conversely, the high risk for SUD developing in ADHD across the lifespan, particularly in the context of comorbid conduct disorder. Although the data remains discordant, it appears that ADHD pharmacotherapy does not increase the risk for SUD. Medication treatment alone does not appear to be particularly effective in treating SUD in currently active substance abusing individuals with ADHD. Structured therapies may be effective in treating adolescents and young adults with ADHD and SUD. Further controlled trials evaluating the sequence and effect of structured psychotherapies and/or ADHD pharmacotherapy on SUD relapse in these groups are warranted.",
keywords = "Adolescence, Attention deficit/hyperactivity disorder, Cognitive-behavioral therapy, Stimulants comorbidity, Substance use disorders",
author = "Zulauf, {Courtney A.} and Sprich, {Susan E.} and Steven Safren and Wilens, {Timothy E.}",
year = "2014",
month = "3",
doi = "10.1007/s11920-013-0436-6",
language = "English (US)",
volume = "16",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders topical collection on child and adolescent disorders

AU - Zulauf, Courtney A.

AU - Sprich, Susan E.

AU - Safren, Steven

AU - Wilens, Timothy E.

PY - 2014/3

Y1 - 2014/3

N2 - Adolescents and young adults with substance use disorders (SUD) and attention deficit/hyperactivity disorder (ADHD) are increasingly presenting in clinical practice. The overlap and role of treatment for these co-occurring disorders remains unclear. A review of the literature was conducted to highlight and update recent evidence on the overlap of ADHD and SUD, the role of ADHD medication on later SUD, and the treatment of ADHD and SUD in adolescents and young adults. Recent work continues to highlight the high risk for comorbid ADHD in patients with SUD; and conversely, the high risk for SUD developing in ADHD across the lifespan, particularly in the context of comorbid conduct disorder. Although the data remains discordant, it appears that ADHD pharmacotherapy does not increase the risk for SUD. Medication treatment alone does not appear to be particularly effective in treating SUD in currently active substance abusing individuals with ADHD. Structured therapies may be effective in treating adolescents and young adults with ADHD and SUD. Further controlled trials evaluating the sequence and effect of structured psychotherapies and/or ADHD pharmacotherapy on SUD relapse in these groups are warranted.

AB - Adolescents and young adults with substance use disorders (SUD) and attention deficit/hyperactivity disorder (ADHD) are increasingly presenting in clinical practice. The overlap and role of treatment for these co-occurring disorders remains unclear. A review of the literature was conducted to highlight and update recent evidence on the overlap of ADHD and SUD, the role of ADHD medication on later SUD, and the treatment of ADHD and SUD in adolescents and young adults. Recent work continues to highlight the high risk for comorbid ADHD in patients with SUD; and conversely, the high risk for SUD developing in ADHD across the lifespan, particularly in the context of comorbid conduct disorder. Although the data remains discordant, it appears that ADHD pharmacotherapy does not increase the risk for SUD. Medication treatment alone does not appear to be particularly effective in treating SUD in currently active substance abusing individuals with ADHD. Structured therapies may be effective in treating adolescents and young adults with ADHD and SUD. Further controlled trials evaluating the sequence and effect of structured psychotherapies and/or ADHD pharmacotherapy on SUD relapse in these groups are warranted.

KW - Adolescence

KW - Attention deficit/hyperactivity disorder

KW - Cognitive-behavioral therapy

KW - Stimulants comorbidity

KW - Substance use disorders

UR - http://www.scopus.com/inward/record.url?scp=84896726223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896726223&partnerID=8YFLogxK

U2 - 10.1007/s11920-013-0436-6

DO - 10.1007/s11920-013-0436-6

M3 - Article

C2 - 24526271

AN - SCOPUS:84896726223

VL - 16

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 3

M1 - 436

ER -